Is nitric oxide involved in the antinociceptive activity of tramadol? Findings in a rat model of neuropathic pain.
The aim of this investigation was to assess the role that NO plays in the antinociceptive activity of tramadol using a rat model of neuropathic pain. Thirty male Wistar rats weighing 200-250 g were randomly divided into five equal groups. The neuropathic pain model used for the study was chronic constrictive injury (CCI) model. Three weeks after the surgical procedure, each rat was tested to assess mechanical threshold in grams using an electronic algometer. After CCI was induced, tramadol hydrochloride was administered by intraperitoneal (i.p.) injection in all groups, and Nomega-nitro-L-arginine (L-NA) and L-arginine were administered i.p. or intrathecally (i.t.) depending on the group. Tramadol was administered in 10 mg/kg doses i.p., L-NA was given in 10 mg/kg doses i.p. and in 30 microg/kg doses i.t.. L-arginine was given in 10 mg/kg doses i. p. and in 50 microg/kg doses i.t.. The multiple agents were given 30 minutes apart from each administration. Intraperitoneal administration of tramadol (Group 1) only increased mechanical threshold in the rats' left hind paw, whereas in i.p. L-NA group (10 mg/kg) (Group 2) produced a significant reduction of the mean mechanical antinociceptive threshold (p<0.05). Like this, in i.t. L-NA group (30 microg/kg) (Group 4) a significant reduction of the mean mechanical antinociceptive threshold (p<0.05) was also observed. The mean threshold values in Group 2 (i.p. tramadol+i.p. L-NA) and Group 4 (i.p. tramadol+i.t. L-NA) were not significantly different. The mean threshold values in Groups 3 (i.p. tramadol+i.p. L-NA+i.p. L-arginine) and 5 (i.p. tramadol+i.t. L-NA+i.t. L-arginine) were also similar. The mean mechanical antinociceptive threshold was significantly increased in Group 3 (i.p. L-NA+L-arginine) and Group 5 (i.t. L-NA+L-arginine) when compared to Group 1 (i.p. tramadol only) (p<0.05 for both). The results of this study support the involvement of the L-arginine/nitric oxide pathway in the antinociceptive effect of tramadol in a rat model of neuropathic pain.
Okuducu
Hasan
H
Kahramanmaraş Obstetrical and Pediatric Hospital, Department of Anesthesiology, and Firat University, Faculty of Medicine, Department of Algology, Turkey.
Onal
Selami Ateş
SA
D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001120:Arginine; D004195:Disease Models, Animal; D007274:Injections, Intraperitoneal; D008297:Male; D009408:Nerve Compression Syndromes / Q000188:drug therapy* / Q000378:metabolism; D009437:Neuralgia / Q000188:drug therapy* / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors; D019335:Nitroarginine; D009619:Nociceptors / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014147:Tramadol / Q000008:administration & dosage / Q000627:therapeutic use*
D000700:Analgesics; D020030:Nitric Oxide Donors; D019335:Nitroarginine; D009569:Nitric Oxide; D014147:Tramadol; D001120:Arginine